Advanced search
Publication Cover
Critical Reviews in Clinical Laboratory Sciences Volume 51, 2014 - Issue 6
Submit an article Journal homepage
621
Views
37
CrossRef citations to date
0
Altmetric
Review Article

Relevance of microRNA in metabolic diseases

Nathan L. PriceVascular Biology and Therapeutics Program;Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine New Haven, CTUSA
,
Cristina M. RamírezVascular Biology and Therapeutics Program;Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine New Haven, CTUSA
&
Carlos Fernández-HernandoVascular Biology and Therapeutics Program;Integrative Cell Signaling and Neurobiology of Metabolism Program, Section of Comparative Medicine, Yale University School of Medicine New Haven, CTUSACorrespondence[email protected]
Pages 305-320 | Received 02 Feb 2014, Accepted 31 May 2014, Published online: 18 Jul 2014

Citations (37)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Anvarsadat Kianmehr, Durdi Qujeq, Abouzar Bagheri & Abdolkarim Mahrooz. (2022) Oxidized LDL-regulated microRNAs for evaluating vascular endothelial function: molecular mechanisms and potential biomarker roles in atherosclerosis. Critical Reviews in Clinical Laboratory Sciences 59:1, pages 40-53.
Read now
Mario Fernández-de Frutos, Inmaculada Galán-Chilet, Leigh Goedeke, Byungwook Kim, Virginia Pardo-Marqués, Ana Pérez-García, J. Ignacio Herrero, Carlos Fernández-Hernando, Jungsu Kim & Cristina M. Ramírez. (2019) MicroRNA 7 Impairs Insulin Signaling and Regulates Aβ Levels through Posttranscriptional Regulation of the Insulin Receptor Substrate 2, Insulin Receptor, Insulin-Degrading Enzyme, and Liver X Receptor Pathway. Molecular and Cellular Biology 39:22.
Read now
J.H. van der Kolk, A. Pacholewska & V. Gerber. (2015) The role of microRNAs in equine medicine: a review. Veterinary Quarterly 35:2, pages 88-96.
Read now

Articles from other publishers (33)

Sharanjot Kaur, Harkomal Verma, Sukhchain Kaur, Prabhakar Gangwar, Anuradha Yadav, Bharti Yadav, Rashmi Rao, Monisha Dhiman & Anil Kumar Mantha. (2023) Understanding the multifaceted role of miRNAs in Alzheimer’s disease pathology. Metabolic Brain Disease.
Crossref
Md. Abdur Rahman, Md. Mahmodul Islam, Md. Abdur Rahman Ripon, Md. Monirul Islam & Mohammad Salim Hossain. (2023) Regulatory Roles of MicroRNAs in the Pathogenesis of Metabolic Syndrome. Molecular Biotechnology.
Crossref
Karla Damián-Medina, Dragan Milenkovic, Yolanda Salinas-Moreno, Karla Fabiola Corral-Jara, Luis Figueroa-Yáñez, Erika Marino-Marmolejo & Eugenia Lugo-Cervantes. (2022) Anthocyanin-rich extract from black beans exerts anti-diabetic effects in rats through a multi-genomic mode of action in adipose tissue. Frontiers in Nutrition 9.
Crossref
Juan Francisco Aranda, Ana Pérez-García, Marta Torrecilla-Parra, Mario Fernández-de Frutos, Yolanda Martín-Martín, Pedro A. Mateos-Gómez, Virginia Pardo-Marqués, Rebeca Busto & Cristina M. Ramírez. (2022) Role of miR-199a-5p in the post-transcriptional regulation of ABCA1 in response to hypoxia in peritoneal macrophages. Frontiers in Cardiovascular Medicine 9.
Crossref
Isabela Costa Fernandes, Talita Adriana Pereira Santos, Daiane Teixeira Oliveira, Victor Fernandes Oliveira, Graziele Galdino Sousa, Luciene Santos Pereira, Natália Rocha Barboza, Elísio Alberto Evangelista & Renata Guerra-Sá. (2022) Effects of the Long-Term Consumption of a High-Sucrose Diet on microRNA Expression in Visceral Adipose Tissue of Rats. Nutrients 14:17, pages 3465.
Crossref
Jianan Zhao, Yu Zhao, Yiyang Hu & Jinghua Peng. (2021) Targeting the GPR119/incretin axis: a promising new therapy for metabolic-associated fatty liver disease. Cellular & Molecular Biology Letters 26:1.
Crossref
Kosmas Margaritis, Georgia Margioula-Siarkou, Styliani Giza, Eleni P. Kotanidou, Vasiliki Regina Tsinopoulou, Athanasios Christoforidis & Assimina Galli-Tsinopoulou. (2021) Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature. International Journal of Molecular Sciences 22:22, pages 12165.
Crossref
Mona Elgazzaz & Eric Lazartigues. (2021) Epigenetic modifications of the renin–angiotensin system in cardiometabolic diseases. Clinical Science 135:1, pages 127-142.
Crossref
Adam Włodarski, Justyna Strycharz, Adam Wróblewski, Jacek Kasznicki, Józef Drzewoski & Agnieszka Śliwińska. (2020) The Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress. International Journal of Molecular Sciences 21:18, pages 6902.
Crossref
Junyan Shen, Xiaoqi Zhu & Hailiang Liu. (2020) MiR-483 induces senescence of human adipose-derived mesenchymal stem cells through IGF1 inhibition. Aging 12:15, pages 15756-15770.
Crossref
Nathan L. Price, Verónica Miguel, Wen Ding, Abhishek K. Singh, Shipra Malik, Noemi Rotllan, Anna Moshnikova, Jakub Toczek, Caroline Zeiss, Mehran M. Sadeghi, Noemi Arias, Ángel Baldán, Oleg A. Andreev, Diego Rodríguez-Puyol, Raman Bahal, Yana K. Reshetnyak, Yajaira Suárez, Carlos Fernández-Hernando & Santiago Lamas. (2019) Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis. JCI Insight 4:22.
Crossref
Feng Zheng, Furong Wang & Zhe Xu. (2019) MicroRNA‑98‑5p prevents bone regeneration by targeting high mobility group AT‑Hook 2. Experimental and Therapeutic Medicine.
Crossref
Ariel Williams, Dara Mc Dougal, Willysha Jenkins, Natasha Greene, Clarlynda Williams-DeVane & K. Sean Kimbro. (2019) Serum miR-17 levels are downregulated in obese, African American women with elevated HbA1c. Journal of Diabetes & Metabolic Disorders 18:1, pages 173-179.
Crossref
Nathan L. PriceNoemi RotllanXinbo ZhangAlberto Canfrán-DuqueTimothy NottoliYajaira SuarezCarlos Fernández-Hernando. (2019) Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development. Circulation Research 124:6, pages 874-880.
Crossref
Alok Tripathi, Kriti Shrinet & Arvind Kumar. (2019) HMGB1 protein as a novel target for cancer. Toxicology Reports 6, pages 253-261.
Crossref
Zijing Lin, Fan Yang, Lijie Sun, Jie Gao, Yan Cao, Hui Qiu & Xiaorong Zhan. (2018) Systematically analyses of the common dysregulated networks to understand the common pathologies between T2D and atherosclerosis. Gene 671, pages 110-116.
Crossref
Wolfgang Poller, Stefanie Dimmeler, Stephane Heymans, Tanja Zeller, Jan Haas, Mahir Karakas, David-Manuel Leistner, Philipp Jakob, Shinichi Nakagawa, Stefan Blankenberg, Stefan Engelhardt, Thomas Thum, Christian Weber, Benjamin Meder, Roger Hajjar & Ulf Landmesser. (2018) Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. European Heart Journal 39:29, pages 2704-2716.
Crossref
Tandi E. Matsha, Andre P. Kengne, Stanton Hector, Desiree L. Mbu, Yandiswa Y. Yako & Rajiv T. Erasmus. (2018) MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus. Oncotarget 9:55, pages 30485-30498.
Crossref
Azadeh Houshmand-Oeregaard, Maren Schrölkamp, Louise Kelstrup, Ninna S Hansen, Line Hjort, Anne Cathrine B Thuesen, Christa Broholm, Elisabeth R Mathiesen, Tine D Clausen, Allan Vaag & Peter Damm. (2018) Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy. Human Molecular Genetics 27:10, pages 1763-1771.
Crossref
Zijing Lin, Xinyu Li, Xiaorong Zhan, Lijie Sun, Jie Gao, Yan Cao & Hui Qiu. (2017) Construction of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in type 2 diabetes mellitus. Journal of Cellular and Molecular Medicine 21:12, pages 3204-3213.
Crossref
Benoit Laffont & Katey J. Rayner. (2017) MicroRNAs in the Pathobiology and Therapy of Atherosclerosis. Canadian Journal of Cardiology 33:3, pages 313-324.
Crossref
Yuqing He, Yuanlin Ding, Biyu Liang, Juanjuan Lin, Taek-Kyun Kim, Haibing Yu, Hanwei Hang & Kai Wang. (2017) A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 18:3, pages 456.
Crossref
Sufang Li, Chengfu Cao, Hong Chen, Junxian Song, Chongyou Lee, Jing Zhang, Feng Zhang, Qiang Geng, Zheng Li & Jingjin Li. (2017) Atheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA network. Molecular Medicine Reports 16:1, pages 817-827.
Crossref
Nathan L. Price & Carlos Fernández-Hernando. (2016) miRNA regulation of white and brown adipose tissue differentiation and function. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:12, pages 2104-2110.
Crossref
Donato Santovito, Virginia Egea & Christian Weber. (2016) Small but smart: MicroRNAs orchestrate atherosclerosis development and progression. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1861:12, pages 2075-2086.
Crossref
Alberto Canfrán-DuqueChin-Sheng LinLeigh GoedekeYajaira SuárezCarlos Fernández-Hernando. (2016) Micro-RNAs and High-Density Lipoprotein Metabolism. Arteriosclerosis, Thrombosis, and Vascular Biology 36:6, pages 1076-1084.
Crossref
Marta Afonso, Pedro Rodrigues, André Simão & Rui Castro. (2016) Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma. Journal of Clinical Medicine 5:3, pages 30.
Crossref
Noemi Rotllan, Nathan Price, Paramita Pati, Leigh Goedeke & Carlos Fernández-Hernando. (2016) microRNAs in lipoprotein metabolism and cardiometabolic disorders. Atherosclerosis 246, pages 352-360.
Crossref
Montse Guardiola, Joan C. Vallvé, Silvio Zaina & Josep Ribalta. (2016) Epigenética en la arteriosclerosis. Clínica e Investigación en Arteriosclerosis 28:2, pages 102-119.
Crossref
Huifen Li, Weihua Huang & Rongcheng Luo. (2015) RETRACTED ARTICLE: The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1. Diagnostic Pathology 10:1.
Crossref
Yuping Wang, Zhichao Liu, Wen Zou, Huixiao Hong, Hong Fang & Weida Tong. (2015) Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH. Biomarkers in Medicine 9:11, pages 1189-1200.
Crossref
Parnika Bhatia, Shikha Raina, Jeetender Chugh & Shilpy Sharma. (2015) miRNAs: early prognostic biomarkers for Type 2 diabetes mellitus?. Biomarkers in Medicine 9:10, pages 1025-1040.
Crossref
Filipe V. Duarte, Carlos M. Palmeira & Anabela P. Rolo. 2015. microRNA: Medical Evidence. microRNA: Medical Evidence 123 154 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.